1-4 of 4
Elizabeth Trehu, MD
Close
Save search
Sort by
Journal Articles

PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

Free
Srdan Verstovsek, MD, Ruben A. Mesa, Lynda M Foltz, MD, Vikas Gupta, MD MRCP, MRCPath, John O. Mascarenhas, MD MS, Ellen K. Ritchie, MD, Ronald Hoffman, MD, Richard T. Silver, MD, Marina Kremyanskaya, MDPhD, Olga Pozdnyakova, MD, Robert P. Hasserjian, MD, Elizabeth Trehu, MD, Mohamed E Salama, MD, Hagop M Kantarjian, MD, Jason Gotlib, MD
Journal: Blood
Blood (2015) 126 (23): 56.
https://doi.org/10.1182/blood.V126.23.56.56
Published: 2015
Journal Articles

Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results

Free
Srdan Verstovsek, MD PhD, Ruben A. Mesa, MD, Lynda M Foltz, MD, Vikas Gupta, MD FRCP, FRCPath, John O Mascarenhas, MD MS, Ellen K. Ritchie, MD, Ronald Hoffman, MD, Richard T. Silver, MD, Marina Kremyanskaya, MDPhD, Olga Pozdnyakova, MD PhD, Robert P Hasserjian, MD, Elizabeth Trehu, MD, Hagop M. Kantarjian, MD, Jason R. Gotlib, MD
Journal: Blood
Blood (2014) 124 (21): 713.
https://doi.org/10.1182/blood.V124.21.713.713
Published: 2014
Journal Articles

Addition of Bortezomib (Velcade) to AML Induction Chemotherapy Is Well Tolerated and Results in a High Complete Remission Rate.

Free
Eyal C. Attar, MD, Daniel J. De Angelo, MD, PhD, Andres Sirulnik, MD, PhD, Martha Wadleigh, MD, Karen K. Ballen, MD, Kenneth B. Miller, MD, Ilene Galinsky, Donna Neuberg, PhD, Elizabeth Trehu, MD, David Schenkein, MD, Richard M. Stone, MD, Philip C. Amrein, MD
Journal: Blood
Blood (2005) 106 (11): 2782.
https://doi.org/10.1182/blood.V106.11.2782.2782
Published: 2005
Journal Articles

Phase II Clinical Study of Bortezomib (VELCADE®) in Patients (pts) with Relapsed / Refractory Non-Hodgkin’s Lymphoma (NHL) and Hodgkin’s Disease (HD).

Free
Sandra J. Strauss, MD, Lenushka Maharaj, MSc, Jim Stec, Anthony Boral, MD, PhD, Elizabeth Trehu, MD, David Schenkein, MD, Simon P. Joel, PhD, T. Andrew Lister, MD
Journal: Blood
Blood (2004) 104 (11): 1386.
https://doi.org/10.1182/blood.V104.11.1386.1386
Published: 2004